Literature DB >> 12212085

[A study on hemostatic and immunological actions of fresh and dry Dihuang].

A Liang1, B Xue, J Wang, J Hao, H Yang, H Yi.   

Abstract

OBJECTIVE: To investigate the difference between fresh and dry Dihuang (Radix Rehmanniae) in hemostatic and immunological actions.
METHODS: The hemostatic action was assessed in aspirin-treated mice; immunological action was assessed by phagocytosis of macrophages in dexamethasone-treated mice; and Con A-induced mitogenesis and LPS-induced alkaline phosphatase activity of splenocytes were determined in thyroxin-treated mice. RESULT: The blood clotting in mice induced by aspirin was inhibited by oral administrations of juice decoction of fresh Dihuang or decoction of dry Dihuang alike. The action of fresh Dihuang juice was stronger than that of dry Dihuang decoction. Oral administrarion of fresh Dihuang juice or decoction for 10 days enhanced LPS-induced alkaline phosphatase activity of splenocytes in thyroxin-treated mice. The juice also enhanced Con A-induced splenocyte mitogenesis. The action of dry Dihuang decoction was weaker than that of fresh juice in increasing LPS-induced alkaline phosphatase activity.
CONCLUSION: It is recommended to follow the tradition of using fresh Dihuang juice or decoction to treat some diseases such as hemorrhagenic troubles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12212085

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Sheng-Di-Da-Huang Decoction Inhibited Inflammation Expressed in Microglia after Intracerebral Hemorrhage in Rats.

Authors:  Min Cai; Zhonghai Yu; Wen Zhang; Li Yang; Jun Xiang; Jingsi Zhang; Zhennian Zhang; Ting Wu; Xiangting Li; Maodong Fu; Xuxia Bao; Xiaofei Yu; Dingfang Cai
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-18       Impact factor: 2.629

Review 2.  Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis.

Authors:  Ziteng Hu; Lidong Gao; Chengxian Li; Alberto Cucco; Shang Wang; Weiling Yuan; Fan Zhang; Shuai Kang; Min Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-18       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.